Filing Details

Accession Number:
0001209191-16-151725
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-22 16:41:23
Reporting Period:
2016-11-21
Filing Date:
2016-11-22
Accepted Time:
2016-11-22 16:41:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885306 Cynosure Inc CYNO Electromedical & Electrotherapeutic Apparatus (3845) 043125110
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1345975 R Michael Davin C/O Cynosure, Inc.
5 Carlisle Road
Westford MA 01886
Chairman, President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2016-11-21 4,222 $30.51 4,222 No 4 M Direct
Class A Common Stock Disposition 2016-11-21 4,222 $45.00 0 No 4 S Direct
Class A Common Stock Acquisiton 2016-11-21 2,007 $29.40 2,007 No 4 M Direct
Class A Common Stock Disposition 2016-11-21 2,007 $45.00 0 No 4 S Direct
Class A Common Stock Acquisiton 2016-11-22 10,055 $29.40 10,055 No 4 M Direct
Class A Common Stock Disposition 2016-11-22 10,055 $45.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (right to buy) Disposition 2016-11-21 4,222 $0.00 4,222 $30.51
Class A Common Stock Employee Stock Option (right to buy) Disposition 2016-11-21 2,007 $0.00 2,007 $29.40
Class A Common Stock Employee Stock Option (right to buy) Disposition 2016-11-22 10,055 $0.00 10,055 $29.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,108 2025-02-11 No 4 M Direct
22,116 2024-02-13 No 4 M Direct
12,061 2024-02-13 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 2/11/2015 grant date.
  3. The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 2/13/2014 grant date.